Anti-EBV Serology, HLA-DR Risk Profiles May Help Identify MS
Adding anti-EBV levels to HLA-DR risk profiles may significantly help discriminate MS cases from controls
Adding anti-EBV levels to HLA-DR risk profiles may significantly help discriminate MS cases from controls
Epstein-Barr virus serology and human leukocyte antigen-DR alleles may significantly help discriminate...
Clinical Research